InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Giuffre Randall Michael, Director. Insider active across 1 company, notably DiaMedica Therapeutics Inc.. Aggregated, 2 filings have been recorded. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
15,026 shares@ US$3.58100.0% of flowVoting Common Shares, no par value per shareSEC:0001235802-22-000001
15,026 shares@ US$3.580.011% mcap50.0% of flowVoting Common Shares, no par value per shareSEC:0001235802-22-000001:0
2 of 2 declarations
About Giuffre Randall Michael
Randall Michael Giuffre is a Director at DiaMedica Therapeutics Inc. He participates in the governance of the company and strategic decision-making. Giuffre brings his expertise in biotechnology to help DiaMedica achieve its goals. His commitment to innovation in the healthcare sector is an asset for the company.
